Prosecutors looking into allegations of insider trading involving OBI Pharma Inc (台灣浩鼎) shares said on Friday that the daughter of Academia Sinica president Wong Chi-huey (翁啟惠) sold some of her shares in the company three months before it announced a failed trial of a new cancer drug, an announcement that sent its stock price plunging.
The Shihlin Prosecutors’ Office in Taipei said that the exact number of shares sold by Wong Yu-shioh (翁郁秀) and the flow of the funds still have to be checked.
Prosecutors have screened data supplied by the Financial Supervisory Commission (FSC) on the 50 biggest traders of OBI Pharma shares prior to when the failed test was announced on Feb. 21, and Wong’s daughter was not among that group, the office said.
The office said it would expand the list to check the top 100 traders of OBI Pharma shares during the period, without specifying how long before the announcement the data cover.
Prosecutors summoned OBI Pharma general manager Amy Huang (黃秀美) for questioning to learn about the process of the clinical trial of its breast cancer drug OBI-822.
They also asked about events leading up to the company reporting that the phase 2.3 study did not meet its designed primary endpoint of progression-free survival at a statistically significant level.
Prosecutors said they hope to shed light on the timing of the sale of OBI Pharma shares by Wong Yu-shioh and other shareholders before the trial failure was made public to see if there was a possibility of insider trading.
The stock plunged sharply for four straight trading sessions in the week following the Feb. 21 announcement, reaching NT$447.5 per share on Feb. 25 after closing at NT$681 per share on Feb. 19.
Wong Chi-huey, a biochemist considered to be an expert on the theory behind OBI Pharma’s drug, has been one of the key figures in the OBI Pharma controversy after endorsing the cancer drug after the failed trial.
Wong Chi-huey was criticized for endorsing the drug, in part because his opinion might have affected OBI Pharma’s share price.
Wong Chi-huey on March 3 defended his actions in a statement, saying he did not hold any shares in Taiwanese biotech companies.
However, Next magazine on Wednesday reported that Wong’s daughter obtained 3 million OBI shares in 2012 at a price of NT$31 per share before it was listed on the emerging stock market.
The company was listed on the over-the-counter market at NT$310 per share the following year.
The revelation fueled accusations against Wong Chi-huey of a conflict of interest and possible insider trading.
Wong Chi-huey, who is in the US, issued a statement on Thursday to apologize for commenting on OBI Pharma and not considering the expectations people have of him as the head of Academia Sinica.
In the statement, he also said that his daughter used money given to her by her parents and her own savings to purchase the OBI Pharma shares because of pain she felt after her aunt on her mother’s side died of breast cancer.
Wong Chi-huey said he was willing to explain the situation at the legislature after returning to Taiwan next week. The legislature has set Thursday next week as the date for a hearing.
Separately, Chinese Nationalist Party (KMT) Legislator William Tseng (曾銘宗), a former FSC chairman who has led the charge in questioning Wong Chi-huey’s actions, responded to accusations that he should have taken action while heading the FSC if there was manipulation of OBI Pharma shares.
Tseng said there were no suspicions of insider trading or stock price manipulation of OBI Pharma when he headed the commission, adding that suspicions only arose after he left the post to take his seat in the legislature at the beginning of last month.
When asked whether he thought it was reasonable that OBI Pharma’s share price last year surged to more than NT$700, Tseng said such a rise was typical of biotech companies.
‘DENIAL DEFENSE’: The US would increase its military presence with uncrewed ships, and submarines, while boosting defense in the Indo-Pacific, a Pete Hegseth memo said The US is reorienting its military strategy to focus primarily on deterring a potential Chinese invasion of Taiwan, a memo signed by US Secretary of Defense Pete Hegseth showed. The memo also called on Taiwan to increase its defense spending. The document, known as the “Interim National Defense Strategic Guidance,” was distributed this month and detailed the national defense plans of US President Donald Trump’s administration, an article in the Washington Post said on Saturday. It outlines how the US can prepare for a potential war with China and defend itself from threats in the “near abroad,” including Greenland and the Panama
A wild live dugong was found in Taiwan for the first time in 88 years, after it was accidentally caught by a fisher’s net on Tuesday in Yilan County’s Fenniaolin (粉鳥林). This is the first sighting of the species in Taiwan since 1937, having already been considered “extinct” in the country and considered as “vulnerable” by the International Union for Conservation of Nature. A fisher surnamed Chen (陳) went to Fenniaolin to collect the fish in his netting, but instead caught a 3m long, 500kg dugong. The fisher released the animal back into the wild, not realizing it was an endangered species at
The High Prosecutors’ Office yesterday withdrew an appeal against the acquittal of a former bank manager 22 years after his death, marking Taiwan’s first instance of prosecutors rendering posthumous justice to a wrongfully convicted defendant. Chu Ching-en (諸慶恩) — formerly a manager at the Taipei branch of BNP Paribas — was in 1999 accused by Weng Mao-chung (翁茂鍾), then-president of Chia Her Industrial Co, of forging a request for a fixed deposit of US$10 million by I-Hwa Industrial Co, a subsidiary of Chia Her, which was used as collateral. Chu was ruled not guilty in the first trial, but was found guilty
DEADLOCK: As the commission is unable to forum a quorum to review license renewal applications, the channel operators are not at fault and can air past their license date The National Communications Commission (NCC) yesterday said that the Public Television Service (PTS) and 36 other television and radio broadcasters could continue airing, despite the commission’s inability to meet a quorum to review their license renewal applications. The licenses of PTS and the other channels are set to expire between this month and June. The National Communications Commission Organization Act (國家通訊傳播委員會組織法) stipulates that the commission must meet the mandated quorum of four to hold a valid meeting. The seven-member commission currently has only three commissioners. “We have informed the channel operators of the progress we have made in reviewing their license renewal applications, and
RSS